| 301 | ANIKAnika Therapeutics, Inc. |
$112.8M |
-9.6% |
2025 |
| 302 | URGNUroGen Pharma Ltd. |
$109.8M |
-139.8% |
2025 |
| 303 | IPSCCentury Therapeutics, Inc. |
$109.2M |
-8.8% |
2025 |
| 304 | MDXHMDxHealth SA |
$107.9M |
-31.1% |
2025 |
| 305 | TBPHTheravance Biopharma, Inc. |
$107.5M |
98.5% |
2025 |
| 306 | ZVRAZevra Therapeutics, Inc. |
$106.5M |
78.2% |
2025 |
| 307 | ZYMEZymeworks Inc. |
$106M |
-76.6% |
2025 |
| 308 | SMTISanara MedTech Inc. |
$103.1M |
-36.4% |
2025 |
| 309 | STROSutro Biopharma, Inc. |
$102.5M |
-186.5% |
2025 |
| 310 | BBNXBeta Bionics, Inc. |
$100.3M |
-73.0% |
2025 |
| 311 | NPCENeuroPace Inc |
$100M |
-21.5% |
2025 |
| 312 | BFLYButterfly Network, Inc. |
$97.6M |
-79.0% |
2025 |
| 313 | BLFSBiolife Solutions Inc |
$96.2M |
-4.8% |
2025 |
| 314 | ISPRIspire Technology Inc. |
$96M |
-34.6% |
2026 |
| 315 | KMTSKestra Medical Technologies, Ltd. |
$95.1M |
-138.4% |
2026 |
| 316 | SIGASiga Technologies Inc |
$94.6M |
24.6% |
2025 |
| 317 | LUNGPulmonx Corp |
$90.5M |
-59.7% |
2025 |
| 318 | CBLLCeribell, Inc. |
$89.1M |
-60.0% |
2025 |
| 319 | BDSXBiodesix Inc |
$88.5M |
-39.8% |
2025 |
| 320 | CYTKCytokinetics Inc |
$88M |
-891.6% |
2025 |
| 321 | DCTHDelcath Systems, Inc. |
$85.2M |
3.2% |
2025 |
| 322 | FDMT4D Molecular Therapeutics, Inc. |
$85.2M |
-164.4% |
2025 |
| 323 | SPRYARS Pharmaceuticals, Inc. |
$84.3M |
-203.3% |
2025 |
| 324 | NRIXNurix Therapeutics, Inc. |
$84M |
-314.9% |
2025 |
| 325 | IRMDIradimed Corp |
$83.8M |
26.8% |
2025 |
| 326 | ARCTArcturus Therapeutics Holdings Inc. |
$82M |
-80.2% |
2025 |
| 327 | FTLFFitlife Brands, Inc. |
$81.5M |
7.8% |
2025 |
| 328 | MGTXMeiraGTx Holdings plc |
$81.4M |
-140.3% |
2025 |
| 329 | ADCTADC Therapeutics SA |
$81.4M |
-175.3% |
2025 |
| 330 | ETONEton Pharmaceuticals, Inc. |
$80M |
-5.8% |
2025 |
| 331 | PDEXPro Dex Inc |
$77.5M |
17.6% |
2026 |
| 332 | SGHTSight Sciences, Inc. |
$77.4M |
-49.7% |
2025 |
| 333 | BNRBurning Rock Biotech Ltd |
$77.2M |
-10.3% |
2025 |
| 334 | CTMXCytomX Therapeutics, Inc. |
$76.2M |
-22.8% |
2025 |
| 335 | AUTLAutolus Therapeutics plc |
$75.4M |
-381.4% |
2025 |
| 336 | ABCLAbCellera Biologics Inc. |
$75.1M |
-194.9% |
2025 |
| 337 | RXRXRecursion Pharmaceuticals, Inc. |
$74.7M |
-863.4% |
2025 |
| 338 | ELMDElectromed, Inc. |
$73.8M |
15.3% |
2026 |
| 339 | CLLSCellectis S.A. |
$72.9M |
-92.7% |
2025 |
| 340 | CGENCompugen Ltd |
$72.8M |
48.6% |
2025 |
| 341 | BCYCBicycle Therapeutics PLC |
$72.6M |
-301.7% |
2025 |
| 342 | ASMBAssembly Biosciences, Inc. |
$72.3M |
-8.5% |
2025 |
| 343 | VRDNViridian Therapeutics, Inc. |
$70.8M |
-483.6% |
2025 |
| 344 | FOCLEdap Tms SA |
$70.5M |
-41.5% |
2025 |
| 345 | BDTXBlack Diamond Therapeutics, Inc. |
$70M |
32.0% |
2025 |
| 346 | PSNLPersonalis, Inc. |
$69.6M |
-116.7% |
2025 |
| 347 | VIRVir Biotechnology, Inc. |
$68.6M |
-638.9% |
2025 |
| 348 | NTLAIntellia Therapeutics, Inc. |
$67.7M |
-609.9% |
2025 |
| 349 | KURAKura Oncology, Inc. |
$67.5M |
-412.9% |
2025 |
| 350 | SPROSpero Therapeutics, Inc. |
$66.8M |
12.8% |
2025 |